2022-11-11T07:50:12-06:00 2021-12-31 861065772 DELOITTE TAX LLP 50 SOUTH SIXTH STREET MINNEAPOLIS MN 55402 990 2021-01-01 473290897 GATES PHILANTHROPY PARTNERS GATE 2067093100 PO BOX 23350 SEATTLE WA 98102 ROBERT ROSEN EXECUTIVE DIRECTOR 2067093100 2022-11-10 1 ROBERT ROSEN XXX-XX-XXXX ANNE FULTON P00941863 6123974000 3 AAL1 IAL1 2021 2022-09-23 18:48:47Z ROBERT ROSEN PO BOX 23350 SEATTLE WA 98102 30155547 0 X WWW.GATESPHILANTHROPYPARTNERS.ORG X 2015 WA GRANTMAKING & CHARITABLE ACTIVITIES TO PROMOTE GLOBAL DEVELOPMENT, GLOBAL HEALTH & EDUCATION 3 0 0 0 0 0 173118845 30131382 0 0 11540 24165 0 0 173130385 30155547 98941913 65145492 0 0 0 0 0 0 0 596077 809740 99537990 65955232 73592395 -35799685 91968050 58428866 16638543 17489044 75329507 40939822 X THE MISSION OF GATES PHILANTHROPY PARTNERS IS TO WORK IN PARTNERSHIP WITH THE BILL & MELINDA GATES FOUNDATION AND PHILANTHROPISTS TO PROMOTE GLOBAL DEVELOPMENT, GLOBAL HEALTH, AND U.S. EDUCATION THROUGH GRANTMAKING AND THE DIRECT CONDUCT OF CHARITABLE ACTIVITIES. 0 0 58146259 58146259 COMBATING COVID-19: CONTROLLING COVID-19 MEANS GETTING VACCINES TO EVERYONE, EVERYWHERE, WHILE MEETING BASIC HUMAN NEEDS SUCH AS ACCESS TO MEDICAL OXYGEN AND EXPEDITING INNOVATIONS IN TESTING AND TREATMENT. FUNDING WAS DIRECTED TO GRANTEE PARTNERS ON THE FRONT LINES WHO TRAINED HEALTH WORKERS, PROVIDED COMMUNITIES WITH ACCESS TO CARE, AND DELIVERED LIFESAVING TOOLS INCLUDING DIAGNOSTICS AND VACCINES. GRANTEES ALSO SUPPORTED RESEARCH AND DEVELOPMENT TO RAPIDLY IDENTIFY NEW INNOVATIONS INCLUDING THERAPEUTICS. 2992609 2992609 U.S. PROGRAMS: REGARDLESS OF ONE'S RACE, ETHNICITY, GENDER, OR INCOME, EVERYONE SHOULD HAVE THE OPPORTUNITY TO LEARN, GROW, AND REACH THEIR FULL POTENTIAL. OUR U.S. PROGRAMS WORK AIMS TO ENSURE THAT EVERYONE IN THE U.S. HAS ACCESS TO LIFE-CHANGING OPPORTUNITIES. OUR U.S. EDUCATION PORTFOLIO AIMS TO ENSURE THAT ALL STUDENTS GRADUATE FROM HIGH SCHOOL AND HAVE AN OPPORTUNITY TO EARN A DEGREE OR CERTIFICATE THAT PREPARES THEM FOR A SUCCESSFUL CAREER AND LIFE. OUR ECONOMIC MOBILITY & OPPORTUNITY PORTFOLIO SEEKS TO CREATE PUBLIC GOODS AND ADDRESS STRUCTURAL BARRIERS THAT LIMIT ECONOMIC SUCCESS FOR AMERICA'S MOST VULNERABLE TO DRAMATICALLY INCREASING MOBILITY FROM POVERTY. 2793832 2793832 EMPOWERMENT & OPPORTUNITY: INVESTING IN WOMEN AND GIRLS HAS BEEN PROVEN TO REDUCE POVERTY, YET TOO MANY GIRLS AND WOMEN ARE DENIED AN EQUAL CHANCE TO LEARN, LEAD, EARN, AND THRIVE. WE MAKE GRANTS IN SEVERAL AREAS TO ADDRESS THESE ISSUES. FIRST, WE GRANT TO WOMEN'S COLLECTIVES, WHICH LIFT UP COMMUNITIES OF WOMEN TO BUILD SOLIDARITY, DEVELOP SUPPORT NETWORKS, POOL SAVINGS, AND SHARE FINANCIAL RISKS. SECOND, WE SUPPORT WOMEN IN LEADERSHIP THROUGH GRANTMAKING TO ENCOURAGE AND CHAMPION WOMEN LEADERS IN KEY FIELDS. THIRD, OUR GRANTS IN WOMEN'S ECONOMIC EMPOWERMENT PUT FINANCIAL TOOLS IN WOMEN'S HANDS TO IMPROVE THEIR LIVES AND THEIR FUTURE. LAST, WE MAKE GRANTS IN FAMILY PLANNING TO INCREASE ACCESS FOR WOMEN AND ADOLESCENTS. 1212792 1212792 GLOBAL HEALTH INNOVATION: OUR GLOBAL HEALTH WORK IS ABOUT TACKLING PREVENTABLE DISEASES THAT IMPERIL THE LIVES OF PEOPLE IN THE POOREST PARTS OF THE WORLD. OUR GRANTS IN GLOBAL HEALTH INNOVATION ACCELERATE SCIENCE - THE DISCOVERY, DEVELOPMENT, AND DELIVERY OF VACCINES, DRUGS, AND DIAGNOSTICS - TO PREVENT AND TREAT NEGLECTED DISEASES AND SAVE LIVES. 554977 GATES PHILANTHROPY PARTNERS (GPP) LEVERAGES THE DEEP PROGRAMMATIC EXPERTISE AND ADMINISTRATIVE INFRASTRUCTURE OF ITS SOLE MEMBER, BILL & MELINDA GATES FOUNDATION (BMGF) TO DEPLOY DONOR CONTRIBUTIONS TO SUPPORT STRONG, EXISTING BMGF-FUNDED PROJECTS WHERE ADDITIONAL FUNDS CAN ACHIEVE IMMEDIATE IMPACT. GPP PROJECTS FOCUS ON CORE THEMES OF BMGF, SUCH AS ELIMINATING DISEASES, CUTTING CHILDHOOD DEATHS IN HALF, ACCELERATING PROGRESS FOR WOMEN AND GIRLS, AND FURTHERING INNOVATION IN US EDUCATION. BY LEVERAGING BMGF'S PROGRAM AND FINANCIAL EXPERTISE, GPP CAN EVALUATE PROJECT OUTCOMES, ANALYZE IMPACT, AND MEASURE PROGRESS IN AN EFFORT TO END INEQUITY AND IMPROVE THE LIVES OF THE WORLD'S POOREST PEOPLE. GPP'S APPROACH TO GRANTMAKING EMPHASIZES COLLABORATION, INNOVATION, EVALUATION, AND, MOST IMPORTANTLY, RESULTS. 1767769 1212792 65700469 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 3 0 1 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 0 0 0 AL AR CA FL GA HI IL KS KY MA MD MI MN MS NC ND NH NJ NM NY OR PA RI SC TN UT VA WA WI WV X X JENNIFER DEGER 2067093100 500 FIFTH AVENUE NORTH SEATTLE WA 98109 CONNIE COLLINGSWORTH DIRECTOR & BOARD CHAIR 1.00 40.00 X 0 975108 72466 ALLAN GOLSTON DIRECTOR 1.00 40.00 X 0 879803 72466 LISA JOHNSEN DIRECTOR & SECRETARY 1.00 40.00 X X 0 454687 70827 ROBERT ROSEN EXECUTIVE DIRECTOR 3.00 40.00 X 0 361404 82449 JONATHAN CASTRODALE TREASURER 1.00 40.00 X 0 325541 84929 0 2996543 383137 0 0 1 0 PIVOT LAB LLC 1201 10TH AVE SUITE C SEATTLE WA 98122 CONTENT AND CREATIVE SERVICES 336853 GENEVA GLOBAL INC 1536 EAST LANCASTER AVE PAOLI PA 19301 STRATEGY EXECUTION 208699 2 749287 29382095 30131382 24165 24165 30155547 0 0 24165 X 15828881 15828881 49316611 49316611 15579 15579 21624 21624 712034 554977 157057 949 949 DONATION PROCESSING FEE 52997 52997 CURRENCY CONVERSION 6448 6448 DUES AND FEES 109 109 65955232 65700469 254763 0 81191317 52028866 10776733 6400000 91968050 58428866 0 16638543 17489044 16638543 17489044 X -11253034 -14155877 86582541 55095699 75329507 40939822 91968050 58428866 X -35799685 1410000 X 0 1 X 1 0 X 4469535 23424174 19430743 173118845 30131382 250574679 4469535 23424174 19430743 173118845 30131382 250574679 118942490 131632189 3550 109919 72630 11540 24165 221804 250796483 0.52490 0.52120 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 65955232 65955232 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 250000 250000 250000 250000 1000000 1500000 1 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTMAKING GRANTMAKING 25056250 EAST ASIA AND THE PACIFIC 0 0 GRANTMAKING GRANTMAKING 3512100 SUB-SAHARAN AFRICA 0 0 GRANTMAKING GRANTMAKING 15958898 NORTH AMERICA 0 0 GRANTMAKING GRANTMAKING 250000 SOUTH ASIA 0 0 GRANTMAKING GRANTMAKING 4539363 0 0 0 0 0 0 49316611 0 49316611 SUB-SAHARAN AFRICA COVID-19 RESPONSE 4058346 ELECTRONIC FUND/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) COVID-19 RESPONSE 800000 ELECTRONIC FUND/WIRE TRANSFER 0 SOUTH ASIA COVID-19 RESPONSE 750000 ELECTRONIC FUND/WIRE TRANSFER 0 SOUTH ASIA COVID-19 RESPONSE 1000000 ELECTRONIC FUND/WIRE TRANSFER 0 SUB-SAHARAN AFRICA COVID-19 RESPONSE 7000000 ELECTRONIC FUND/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WOMEN EMPOWERMENT 500000 ELECTRONIC FUND/WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC IMPROVE WATER, SANITATION, AND HYGIENE 170031 ELECTRONIC FUND/WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC COVID-19 RESPONSE 767100 ELECTRONIC FUND/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WOMEN EMPOWERMENT 503832 ELECTRONIC FUND/WIRE TRANSFER 0 SUB-SAHARAN AFRICA IMPROVE WATER, SANITATION, AND HYGIENE 90199 ELECTRONIC FUND/WIRE TRANSFER 0 SUB-SAHARAN AFRICA COVID-19 RESPONSE 599639 ELECTRONIC FUND/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) COVID-19 RESPONSE 18000000 ELECTRONIC FUND/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) COVID-19 RESPONSE 1096250 ELECTRONIC FUND/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) COVID-19 RESPONSE 1000000 ELECTRONIC FUND/WIRE TRANSFER 0 SOUTH ASIA WOMEN EMPOWERMENT 340000 ELECTRONIC FUND/WIRE TRANSFER 0 SUB-SAHARAN AFRICA COVID-19 RESPONSE 1688652 ELECTRONIC FUND/WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC COVID-19 RESPONSE 2500000 ELECTRONIC FUND/WIRE TRANSFER 0 SOUTH ASIA COVID-19 RESPONSE 1700000 ELECTRONIC FUND/WIRE TRANSFER 0 SUB-SAHARAN AFRICA COVID-19 RESPONSE 800000 ELECTRONIC FUND/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) VACCINE DEVELOPMENT 50000 ELECTRONIC FUND/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WOMEN EMPOWERMENT 700000 ELECTRONIC FUND/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) COVID-19 RESPONSE 1600000 ELECTRONIC FUND/WIRE TRANSFER 0 NORTH AMERICA WOMEN EMPOWERMENT 250000 ELECTRONIC FUND/WIRE TRANSFER 0 SOUTH ASIA VACCINE DEVELOPMENT 749363 ELECTRONIC FUND/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) COVID-19 RESPONSE 2500000 ELECTRONIC FUND/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) VACCINE DEVELOPMENT 10000 ELECTRONIC FUND/WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC IMPROVE WATER, SANITATION, AND HYGIENE 74969 ELECTRONIC FUND/WIRE TRANSFER 0 SUB-SAHARAN AFRICA IMPROVE WATER, SANITATION, AND HYGIENE 18230 ELECTRONIC FUND/WIRE TRANSFER 0 15 9 1 0 0 0 0 0 PART I, LINE 2: GATES PHILANTHROPY PARTNERS LEVERAGES THE PROCESS AND EXPERTISE OF BILL & MELINDA GATES FOUNDATION FOR SOLICITING, ANALYZING, AND REVIEWING GRANT PROPOSALS. GRANTEES SIGN WRITTEN AGREEMENTS THAT SPECIFY THE GRANT PURPOSE, TIMING OF PERIODIC REPORTS, AND REQUIRE A FINAL REPORT THAT ACCOUNTS FOR HOW GRANT FUNDS WERE SPENT. GATES PHILANTHOPY PARTNERS HAS THE AUTHORITY TO WITHHOLD AND/OR RECOVER ANY GRANT FUNDS THAT ARE, OR APPEAR TO BE, MISUSED. FROM TIME TO TIME, SPOT AUDITS ARE CONDUCTED ON SELECTED GRANTEES TO MONITOR WHETHER THE GRANTEES ARE COMPLYING WITH THE TERMS OF THEIR GRANT AGREEMENTS. ADDITIONALLY, OUTSIDE EXPERTS ARE PERIODICALLY ENGAGED TO PERFORM EVALUATION OF SELECTED GRANTEES TO ENSURE THE FUNDS ARE BEING USED FOR THE PURPOSES OF THE GRANT. PART I, LINE 3: GRANTS ARE REPORTED ON THE ACCRUAL BASIS OF ACCOUNTING. PART III ACCOUNTING METHOD: PART II, LINE 1(A): MULTIPLE GRANTS BENEFITTED MORE THAN ONE REGION AROUND THE WORLD. FOR PURPOSES OF 990 REPORTING, THE REGION LISTED IS THE REGION THAT RECEIVED A MAJORITY OF THE BENEFIT. THESE GRANTS ARE EXPECTED TO HAVE A GLOBAL IMPACT IN FUTURE YEARS. PART II, LINE 1: GRANTS ARE REPORTED ON ACCRUAL BASIS OF ACCOUNTING. 1 BILL & MELINDA GATES MEDICAL RESEARCH INSTITUTE ONE KENDALL SQUARE BUILDING 600 SUITE 6-301 CAMBRIDGE MA 02139 821808476 501(C)(3) 2827278 0 COVID-19 RESPONSE BRIGHAM AND WOMEN'S HOSPITAL INC 75 FRANCIS STREET BOSTON MA 021156110 042312909 501(C)(3) 1500000 0 COVID-19 RESPONSE CHANGEORG CHARITABLE FOUNDATION INC 383 RHODE ISLAND STREET SAN FRANCISCO CA 94103 475546698 501(C)(3) 500000 0 WOMEN EMPOWERMENT NATIONAL STUDENT CLEARINGHOUSE RESEARCH CENTER 2300 DULLES STATION BLVD SUITE 220 HERNDON VA 20171 271255674 992609 0 SUPPORT POSTSECONDARY EDUCATION NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC 250 MASSACHUSETTS AVENUE CAMBRIDGE MA 02139 020567016 2088377 0 COVID-19 RESPONSE NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC 250 MASSACHUSETTS AVENUE CAMBRIDGE MA 02139 020567016 870617 0 COVID-19 RESPONSE ONEGOAL 180 N WABASH AVE SUITE 800 CHICAGO IL 60601 562369898 501(C)(3) 750000 0 SUPPORT POSTSECONDARY EDUCATION OREGON HEALTH & SCIENCE UNIVERSITY 3181 SW SAM JACKSON PARK ROAD L106OPAM PORTLAND OR 97239 931176109 50000 0 VACCINE DEVELOPMENT PROSPERITY NOW 1200 G STREET NW SUITE 400 WASHINGTON DC 20005 521141804 501(C)(3) 500000 0 COVID-19 RESPONSE UNIVERSITY OF SOUTHERN CALIFORNIA USC RACE AND EQUITY CENTER 635 DOWNEY WAY VPD SUITE 214 LOS ANGELES CA 90089 951642394 501(C)(3) 250000 0 SUPPORT POSTSECONDARY EDUCATION WILLIAM MARSH RICE UNIVERSITY 6100 MAIN STREET MS-258 HOUSTON TX 770051892 741109620 501(C)(3) 1000000 0 SUPPORT POSTSECONDARY EDUCATION THE SCRIPPS RESEARCH INSTITUTE 11119 NORTH TORREY PINES ROAD SUITE 100 LA JOLLA CA 92037 330435954 501(C)(3) 4500000 0 COVID-19 RESPONSE 8 3 PART I, LINE 2: GATES PHILANTHROPY PARTNERS LEVERAGES THE PROCESS AND EXPERTISE OF BILL & MELINDA GATES FOUNDATION FOR SOLICITING, ANALYZING, AND REVIEWING GRANT PROPOSALS. GRANTEES SIGN WRITTEN AGREEMENTS THAT SPECIFY THE GRANT PURPOSE, TIMING OF PERIODIC REPORTS, AND REQUIRE A FINAL REPORT THAT ACCOUNTS FOR HOW GRANT FUNDS WERE SPENT. GATES PHILANTHOPY PARTNERS HAS THE AUTHORITY TO WITHHOLD AND/OR RECOVER ANY GRANT FUNDS THAT ARE, OR APPEAR TO BE, MISUSED. FROM TIME TO TIME, SPOT AUDITS ARE CONDUCTED ON SELECTED GRANTEES TO MONITOR WHETHER THE GRANTEES ARE COMPLYING WITH THE TERMS OF THEIR GRANT AGREEMENTS. ADDITIONALLY, OUTSIDE EXPERTS ARE PERIODICALLY ENGAGED TO PERFORM EVALUATION OF SELECTED GRANTEES TO ENSURE THE FUNDS ARE BEING USED FOR THE PURPOSES OF THE GRANT. 0 0 0 0 0 0 0 0 0 CONNIE COLLINGSWORTH DIRECTOR & BOARD CHAIR 0 922484 0 0 0 52624 0 43500 0 28966 0 1047574 0 0 ALLAN GOLSTON DIRECTOR 0 844522 0 142 0 35139 0 43500 0 28966 0 952269 0 0 LISA JOHNSEN DIRECTOR & SECRETARY 0 422291 0 5407 0 26989 0 43500 0 27327 0 525514 0 0 ROBERT ROSEN EXECUTIVE DIRECTOR 0 347163 0 0 0 14241 0 43500 0 38949 0 443853 0 0 JONATHAN CASTRODALE TREASURER 0 314995 0 10000 0 546 0 43500 0 41429 0 410470 0 0 PART I, LINE 3 THE TOP MANAGEMENT OFFICIAL IS UNCOMPENSATED BY THE REPORTING ORGANIZATION. THE REPORTING ORGANIZATION RELIES ON BILL & MELINDA GATES FOUNDATION, ITS SOLE MEMBER, TO ESTABLISH COMPENSATION FOR THE TOP MANAGEMENT OFFICIAL. FORM 990, PART VI, SECTION A, LINE 2 CONNIE COLLINGSWORTH, ROBERT ROSEN, LISA JOHNSEN, ALLAN GOLSTON, AND JONATHAN CASTRODALE HAVE A BUSINESS RELATIONSHIP AS EMPLOYEES OF THE BILL & MELINDA GATES FOUNDATION. FORM 990, PART VI, SECTION A, LINE 6 THE SOLE MEMBER OF GATES PHILANTHROPY PARTNERS IS BILL & MELINDA GATES FOUNDATION. FORM 990, PART VI, SECTION A, LINE 7A BILL & MELINDA GATES FOUNDATION, THE SOLE MEMBER OF GATES PHILANTHROPY PARTNERS, HAS THE AUTHORITY TO APPOINT AND REMOVE DIRECTORS. FORM 990, PART VI, SECTION A, LINE 7B BILL & MELINDA GATES FOUNDATION, THE SOLE MEMBER OF GATES PHILANTHROPY PARTNERS, HAS THE AUTHORITY TO AMEND THE ARTICLES OF INCORPORATION, ADOPT A PLAN OF MERGER OR CONSOLIDATION, AUTHORIZE THE SALE, LEASE, OR EXCHANGE OF ALL OR SUBSTANTIALLY ALL OF THE ASSETS OF THE ORGANIZATION, AUTHORIZE THE VOLUNTARY DISSOLUTION OF THE ORGANIZATION AND ADOPTION OF A PLAN FOR THE DISTRIBUTION OF THE ASSETS OF THE ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS PREPARED BY A THIRD-PARTY ACCOUNTANT. AFTER PREPARATION, IT IS REVIEWED IN DETAIL BY THE TREASURER OF GATES PHILANTHROPY PARTNERS, AND THE TAX TEAM AND CONTROLLER OF BILL & MELINDA GATES FOUNDATION, THE SOLE MEMBER OF GATES PHILANTHROPY PARTNERS. A COPY OF THE FORM 990 IS PROVIDED TO THE ENTIRE BOARD OF GATES PHILANTHROPY PARTNERS PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C ALL OFFICERS, DIRECTORS AND KEY EMPLOYEES ARE CONSIDERED "COVERED PERSONS" FOR THE ORGANIZATION'S CONFLICT OF INTEREST POLICY, AND AS SUCH, ARE REQUIRED TO ANNUALLY DISCLOSE ANY RELATIONSHIPS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST INVOLVING THE ORGANIZATION. IN ADDITION, ANY TRANSACTIONS BETWEEN THE ORGANIZATION AND ANY OF THESE INDIVIDUALS (OR THEIR FAMILY MEMBERS OR AN AFFILIATED ENTITY) MUST BE DISCLOSED TO THE SECRETARY. IF THE SECRETARY HAS A POTENTIAL CONFLICT OF INTEREST, IT MUST BE DISCLOSED TO THE EXECUTIVE DIRECTOR. THE SECRETARY AND EXECUTIVE DIRECTOR ARE RESPONSIBLE FOR REVIEWING THE ANNUAL CONFLICT OF INTEREST DISCLOSURES AND RESOLVING ANY POTENTIAL CONFLICT OF INTERESTS THAT MAY ARISE. THE COVERED PERSON IS REQUIRED TO REFRAIN FROM USING THEIR PERSONAL INFLUENCE TO ENCOURAGE THE ORGANIZATION TO ENTER INTO THE COVERED TRANSACTION. ADDITIONALLY, THEY MUST NOT PARTICIPATE IN ANY DISCUSSIONS REGARDING THE COVERED TRANSACTIONS WITH OFFICERS, DIRECTORS AND EMPLOYEES OF THE ORGANIZATION, EXCEPT TO RESPOND TO REQUESTS FOR INFORMATION. IF THE TRANSACTION IS DEEMED TO BE REASONABLE BY THE DISINTERESTED DIRECTORS (IN THE CASE OF A CONFLICT INVOLVING A DIRECTOR OR THE EXECUTIVE DIRECTOR) OR EXECUTIVE DIRECTOR (IN THE CASE OF A CONFLICT INVOLVING ANOTHER OFFICER OR KEY EMPLOYEE), THE ORGANIZATION MAY ENTER INTO THE TRANSACTION, AS LONG AS IT IS FAIR AND REASONABLE TO THE ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 15 GATES PHILANTHROPY PARTNERS DID NOT COMPENSATE ITS EXECUTIVE DIRECTOR OR OTHER OFFICERS. THE ORGANIZATION HAD NO EMPLOYEES AND THE OFFICERS WERE COMPENSATED BY BILL & MELINDA GATES FOUNDATION, THE SOLE MEMBER OF GATES PHILANTHROPY PARTNERS. BILL & MELINDA GATES FOUNDATION HAS A PROCESS TO DETERMINE COMPENSATION WHICH INCLUDES APPROVAL BY INDEPENDENT PERSONS, COMPARABILITY DATA, AND CONTEMPORANEOUS DOCUMENTATION. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. GATES PHILANTHROPY PARTNERS' FINANCIAL STATEMENTS ARE CONSOLIDATED WITH BILL & MELINDA GATES FOUNDATION, AND THE CONSOLIDATED FINANCIAL STATEMENTS ARE AVAILABLE AT WWW.GATESFOUNDATION.ORG. FORM 990, PART IX, LINE 11G OTHER CONSULTING SERVICES: PROGRAM SERVICE EXPENSES 22,118. MANAGEMENT AND GENERAL EXPENSES 157,057. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 179,175. STRATEGY EXECUTION: PROGRAM SERVICE EXPENSES 532,859. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 532,859. FORM 990, PART XI, LINE 9: RETURN OF GRANT FUNDS 1,410,000. BILL & MELINDA GATES FOUNDATION (BMGF) PO BOX 23350 SEATTLE WA 98102 562618866 GRANTMAKING FOUNDATION WA 501(C)(3) PF N/A 0 BILL & MELINDA GATES MEDICAL RESEARCH INSTITUTE ONE KENDALL SQ BLDG 600 CAMBRIDGE MA 02139 821808476 MEDICAL RESEARCH WA 501(C)(3) 4 BILL & MELINDA GATES FOUNDATION 1 BILL & MELINDA GATES FOUNDATION TRUST (BMGFT) PO BOX 23350 SEATTLE WA 98102 911663695 GRANTMAKING FOUNDATION WA 501(C)(3) PF N/A 0 ACCELERATOR GPS SIDE CAR FUND LP PO BOX 13329 RESEARCH TRIANGLE PARK NC 27709 814667411 PROGRAM RELATED INVESTMENT OF BMGF DE 0 0 GREENBRIAR AS HOLDINGS LP 555 THEODORE FREMD AVE STE A-201 RYE NY 10580 981208908 INVESTMENT OF BMGFT CJ 0 0 GREENBRIAR EQUITY FUND III AIV MM NV LP 555 THEODORE FREMD AVE STE A-201 RYE NY 10580 811112433 INVESTMENT OF BMGFT DE 0 0 GREENBRIAR EQUITY FUND III AIV NV LP 555 THEODORE FREMD AVE STE A-201 RYE NY 10580 981208417 INVESTMENT OF BMGFT CJ 0 0 GREENBRIAR EQUITY FUND III AIV SK NV LP 555 THEODORE FREMD AVE STE A-201 RYE NY 10580 473805287 INVESTMENT OF BMGFT DE 0 0 GREENBRIAR EQUITY FUND III-A AIV WFCI LP 555 THEODORE FREMD AVE STE A-201 RYE NY 10580 981219020 INVESTMENT OF BMGFT CJ 0 0 GREENBRIAR EQUITY FUND III-A LP 555 THEODORE FREMD AVE STE A-201 RYE NY 10580 461543216 INVESTMENT OF BMGFT DE 0 0 THE GLOBAL GOOD FUND I LLC 3150 139TH AVE SE BELLEVUE WA 98005 272796838 INVESTMENT OF BMGFT DE 0 0 AFRICAN AGRICULTURAL CAPITAL FUND LLC 6TH FLOOR TOWER A CYBERCITY EBENE MP 981017696 PROGRAM RELATED INVESTMENT OF BMGF MP N/A C 1 GREENBRIAR AS LP 555 THEODORE FREMD AVE STE A-201 RYE NY 10580 981208754 INVESTMENT OF BMGFT CJ N/A C 0 CHROMIUM FUND LP 712 FIFTH AVE SUITE 17F NEW YORK NY 10019 871458828 INVESTMENT OF BMGFT CJ N/A C 0 0 1 1 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0 BILL & MELINDA GATES MEDICAL RESEARCH INSTITUTE B 2827278 CASH GRANT FOR COVID-19 RESPONSE